Related Experiment Videos
Adhesion molecule polymorphisms in chronic renal allograft failure.
A J McLaren1, S E Marshall, N A Haldar
1Nuffield Department of Surgery, John Radcliffe Hospital, Oxford, England, United Kingdom. Amcla007@aol.com
Kidney International
|May 7, 1999
Summary
Intercellular adhesion molecule-1 (ICAM-1) gene variants may predict chronic allograft failure in kidney transplant recipients. Specific ICAM-1 polymorphisms are associated with increased risk and faster graft loss, suggesting a genetic predisposition.
Area of Science:
- Nephrology
- Immunogenetics
- Transplantation immunology
Background:
- Chronic allograft failure (CAF) is a primary cause of late kidney transplant loss.
- Adhesion molecules, such as ICAM-1, are implicated in leukocyte migration during rejection.
- Understanding genetic factors influencing CAF is crucial for improving long-term graft survival.
Purpose of the Study:
- To investigate the association between intercellular adhesion molecule-1 (ICAM-1) polymorphisms and chronic allograft failure (CAF) in renal transplant recipients.
- To determine if specific ICAM-1 variants are linked to an increased risk or accelerated progression of CAF.
Main Methods:
- Retrospective analysis of renal transplant recipients between 1985 and 1996.
- Genotyping for polymorphisms in ICAM-1, E-selectin, and L-selectin.
- Comparison of allele frequencies in CAF patients, long-term survivors, and UK controls.
Main Results:
- A variant allele in ICAM-1 exon 4 (R241) was significantly more frequent in CAF recipients than in long-term survivors and controls (P=0.015, P=0.025).
- Another ICAM-1 variant in exon 6 (E469) was associated with more rapid graft failure due to CAF (P=0.033).
Conclusions:
- ICAM-1 polymorphisms may serve as a genetic risk factor for developing CAF.
- The identified ICAM-1 variants, located in critical functional domains, could influence adhesion molecule activity, costimulation, or act as minor histocompatibility antigens.
- These findings highlight the potential role of host genetics in predicting CAF outcomes.